XML 19 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Equity (Tables)
12 Months Ended
Dec. 31, 2019
Schedule of weighted-average assumptions used in calculation of fair value of stock options

The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:

 

 

 

 

 

 

 

 

 

2019

 

2018

 

Expected life

    

5.75 years

    

6.20 years

 

Weighted average volatility

 

71

%

70

%

Forfeiture rate

 

20

%

15

%

Weighted average risk-free interest rate

 

2.52

%

2.74

%

Expected dividend rate

 

 0

%

 0

%

 

Summary of status of non-vested stock options

A summary of the status of the Company’s non-vested stock options at December 31 and changes during the year is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

    

2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Weighted

    

 

    

Weighted

 

 

 

 

Average

 

 

 

Average

 

 

Number of

 

Grant Date

 

Number of

 

Grant Date

 

    

Options

    

Fair Value

    

Options

    

Fair Value

 

 

 

 

 

 

 

 

 

 

 

Non-vested stock options at January 1

 

292,315

 

$

2.61

 

238,871

 

$

4.27

Granted

 

1,328,718

 

$

1.32

 

224,000

 

$

1.94

Vested

 

(902,268)

 

$

1.40

 

(122,647)

 

$

4.15

Exercised

 

 —

 

 

 —

 

 —

 

 

 —

Forfeited/Expired/Exchanged

 

(48,780)

 

$

2.14

 

(47,909)

 

$

3.82

Non-vested stock options at December 31

 

669,985

 

$

1.71

 

292,315

 

$

2.61

 

Schedule of unrecognized compensation cost

At December 31, 2019, there was $300,000 of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Plan that will be recognized over a remaining weighted average period of 1.4 years. That cost is expected to be recognized in future years as follows:

 

 

 

 

 

2020

 

 

207,000

2021

 

 

84,000

2022

 

 

9,000

 

 

$

300,000

 

Schedule of recognized compensation cost

The recognized compensation cost associated with the Plan is as follows:

 

 

 

 

 

 

 

 

 

    

2019

    

2018

Research and development

 

$

174,000

 

$

145,000

General and administrative

 

 

394,000

 

 

79,000

Effect on net loss

 

$

568,000

 

$

224,000

Effect on net loss per share

 

$

0.02

 

$

0.01

 

Summary of warrants outstanding

The following table summarizes the number of warrants, the weighted average exercise price, and weighted average life (in years) by price for both total outstanding warrants and total exercisable warrants at December 31,2019:

 

 

 

 

 

 

 

 

 

 

 

Total Outstanding Warrants

 

 

 

 

Wtd. Avg.

 

Remaining

 

 

 

 

Exercise

 

Life

Exercise Price

    

Warrants

    

Price

    

(in years)

$1.80

 

80,000

 

$

1.80

 

1.14

 

Equity Incentive Plan [Member]  
Schedule of share-based compensation activity

Activity under the Plan is as follows:

 

 

 

 

 

 

 

    

2019

    

2018

Reserved but unissued shares under the Plan, beginning of year

 

1,296,462

 

191,656

Increases in the number of authorized shares under the Plan

 

1,236,346

 

1,106,088

Grants of stock options

 

(1,328,718)

 

(224,000)

Stock option forfeitures

 

77,937

 

337,583

Exercise of stock options

 

 —

 

 —

Stock grants

 

 —

 

(114,865)

Stock grant forfeitures

 

 —

 

 —

Reserved but unissued shares under the Plan, end of year

 

1,282,027

 

1,296,462

 

Warrant [Member]  
Schedule Of warrant activity

A summary of the Company’s warrant activity and related information is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

 

2018

 

    

 

    

Weighted

    

 

    

Weighted

 

 

 

 

Average

 

 

 

Average

 

 

 

 

Exercise

 

 

 

Exercise

 

 

Warrants

 

Price

 

Warrants

 

Price

Outstanding at January 1

 

2,495,784

 

$

3.98

 

2,495,784

 

$

3.98

Granted

 

 —

 

 

 —

 

 —

 

 

 —

Exercised

 

 —

 

 

 —

 

 —

 

 

 —

Forfeited/Expired

 

(2,415,784)

 

$

4.05

 

 —

 

 

 —

Outstanding at December 31

 

80,000

 

$

1.80

 

2,495,784

 

$

3.98

 

Stock Options [Member]  
Schedule of stock option activity

 

 

 

 

 

 

 

 

2019

 

2018

 

Expected life

    

5.75 years

    

6.20 years

 

Weighted average volatility

 

71

%

70

%

Forfeiture rate

 

20

%

15

%

Weighted average risk-free interest rate

 

2.52

%

2.74

%

Expected dividend rate

 

 0

%

 0

%

 

A summary of the Company’s stock option activity and related information is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

 

2018

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

Average

 

 

Options to

 

Weighted

 

Remaining

 

Options to

 

Weighted

 

Remaining

 

 

Purchase

 

Average

 

Contractual

 

Purchase

 

Average

 

Contractual

 

 

Common

 

Exercise

 

Life (in

 

Common

 

Exercise

 

Life (in

 

    

Stock

    

Price

    

years)

    

Stock

    

Price

    

years)

Outstanding at January 1

 

880,277

 

$

4.32

 

6.49

 

993,860

 

$

4.81

 

6.94

Granted

 

1,328,718

 

$

1.32

 

9.16

 

224,000

 

$

1.94

 

9.23

Exercised

 

 —

 

 

 —

 

 —

 

 —

 

 

 —

 

 —

Forfeited/Expired/Exchanged

 

(77,937)

 

$

2.11

 

 —

 

(337,583)

 

$

4.19

 

 —

Outstanding at December 31

 

2,131,058

 

$

2.53

 

7.99

 

880,277

 

$

4.32

 

9.04

Exercisable at December 31

 

1,461,073

 

$

2.90

 

7.58

 

587,962

 

$

5.17

 

6.49

 

Inducement Stock Options [Member]  
Schedule of weighted-average assumptions used in calculation of fair value of stock options

The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:

 

 

 

 

 

 

 

2019

 

Expected life

    

5.75

years

Weighted average volatility

 

71

%  

Forfeiture rate

 

20

%  

Weighted average risk-free interest rate

 

2.55

%  

Expected dividend rate

 

 0

%  

 

Consultant Plan [Member]  
Schedule of share-based compensation activity

Activity under the Consultant Plan is as follows:

 

 

 

 

 

 

 

    

2019

    

2018

Reserved but unissued shares under the Consultant Plan at January 1

 

199,705

 

99,159

Increases in the number of authorized shares under the Consultant Plan

 

437

 

110,546

Stock grants

 

(10,000)

 

(10,000)

Reserved but unissued shares under the Consultant Plan at Period End

 

190,142

 

199,705